The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2)

被引:190
作者
Lan, Ruth Y. [1 ]
Selmi, Carlos [1 ]
Gershwin, M. Eric [1 ]
机构
[1] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Genome & Biomed Sci Facil, Davis, CA 95616 USA
关键词
FoxP3; interleukin-2; interleukin-17; regulatory T cells; autoimmunity;
D O I
10.1016/j.jaut.2008.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Signaling through IL-2 induces the activation of pathways that lead to the proliferation, survival and cytokine production of effector T cells. However, through negative feedback mechanisms, internalization of the IL-2 receptor, induction of activation-induced cell death, and the generation of regulatory T cells, IL-2 also promotes the suppression of inflammatory responses. In regulatory T cells, IL-2 signaling upregulates the expression of FoxP3. Regulatory T cell induction by TGF-beta also requires IL-2. Additionally, pro-inflammatory and pro-survival pathways involving PI3K upon IL-2 stimulation is inhibited by PTEN in regulatory T cells. Importantly, IL-2 signaling is key for the development, expansion and maintenance of regulatory T cells. However, gamma(c) cytokines can replace requirements for IL-2 in regulatory T cells, although not with the same efficacy. The dual roles of IL-2 in inflammation are demonstrated in that mice deficient in both FoxP3 and IL-2 display less severe symptoms compared to FoxP3 deficient mice. Finally, IL-2 not only plays a key role in the induction of effector T cells and regulatory T cells, it also inhibits IL-17 producing T cells. By understanding complex dynamics of IL-2 interactions in the inflammatory response, therapies may be developed or modified for regulating immune related diseases. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 62 条
[1]
IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells [J].
Ahmadzadeh, Mojgan ;
Antony, Paul A. ;
Rosenberg, Steven A. .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (03) :294-302
[2]
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis [J].
Aoki, Christopher A. ;
Roifman, Chaim M. ;
Lian, Zhe-Xiong ;
Bowlus, Christopher L. ;
Norman, Gary L. ;
Shoenfeld, Yehuda ;
Mackay, Ian R. ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2006, 27 (01) :50-53
[3]
A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection [J].
Bassiri, H ;
Carding, SR .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :5945-5954
[4]
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells [J].
Bensinger, SJ ;
Walsh, PT ;
Zhang, JD ;
Carroll, M ;
Parsons, R ;
Rathmell, JC ;
Thompson, CB ;
Burchill, MA ;
Farrar, MA ;
Turka, LA .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5287-5296
[5]
Activation, coactivation, and costimulation of resting human natural killer cells [J].
Bryceson, Yenan T. ;
March, Michael E. ;
Ljunggren, Hans-Gustaf ;
Long, Eric O. .
IMMUNOLOGICAL REVIEWS, 2006, 214 :73-91
[6]
Interleukin-2 receptor signaling in regulatory T cell development and homeostasis [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vang, Kieng B. ;
Farrar, Michael A. .
IMMUNOLOGY LETTERS, 2007, 114 (01) :1-8
[7]
IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vogtenhuber, Christine ;
Blazar, Bruce R. ;
Farrar, Michael A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (01) :280-290
[8]
The thymus as an inductive site for T lymphopoiesis [J].
Ciofani, Maria ;
Zuniga-Pfluecker, Juan Carlos .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2007, 23 :463-493
[9]
Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific kill T cells dentritic cells [J].
Dhodapkar, KM ;
Krasovsky, J ;
Williamson, B ;
Dhodapkar, MV .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :125-133
[10]
New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling [J].
Dik, WA ;
Pike-Overzet, K ;
Weerkamp, F ;
de Ridder, D ;
de Haas, EFE ;
Baert, MRM ;
van der Spek, P ;
Koster, EEL ;
Reinders, MJT ;
van Dongen, JJM ;
Langerak, AW ;
Staal, FJT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (11) :1715-1723